2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Hemophilia A or B: new trials by email Literature Review of Hemophilia A or B trials Research Report on Hemophilia A or B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PF-06741086 Long-term Treatment in Severe Hemophilia PF-06741086 - Hemophilia A or B | Phase 2 | Completed | Pfizer | 20 | 2018-05-30 | 2021-07-27 |
| PF-06741086 Multiple Dose Study in Severe Hemophilia PF-06741086 - Hemophilia A or B | Phase 2 | Completed | Pfizer | 27 | 2017-03-08 | 2019-12-04 |
Hemophilia A (2)
Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Coagulation Protein Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2)
marstacimab (2)
Pfizer (2)
Chile (2) · Croatia (2) · Poland (2) · South Africa (2) · Switzerland (2) · United States (2) · Brazil (1)
PMID 42698050, PMID 35999026, PMID 36220152
2016 (1), 2017 (1)